← Open Payments lookup

ELIZABETH THOMAS: Open Payments

NPI 1326773771 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,220 in 94 payments from 19 companies in 2025. Trend: 2023 $1,575 · 2024 $1,886 · 2025 $2,220

Food & beverage: $2,220
CompanyPaymentsAmount
Janssen Biotech, Inc.26$607
Ardelyx, Inc.12$364
ABBVIE INC.10$223
PFIZER INC.10$199
Madrigal Pharmaceuticals4$109
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$92
Regeneron Healthcare Solutions, Inc.4$80
Ipsen Biopharmaceuticals, Inc3$73
Takeda Pharmaceuticals U.S.A., Inc.3$66
Lilly USA, LLC3$65

Products named: TREMFYA, IBSRELA, DUPIXENT, CREON, XELJANZ, REZDIFFRA, XIFAXAN, LINZESS.

Industry payments across DC — which companies pay providers there.